17099625

Source:http://linkedlifedata.com/resource/pubmed/id/17099625

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010711, umls-concept:C0023487, umls-concept:C0023866, umls-concept:C0087111, umls-concept:C0282443, umls-concept:C0596545, umls-concept:C1514873, umls-concept:C1519814, umls-concept:C1546857, umls-concept:C1552617, umls-concept:C1556066, umls-concept:C1619636
pubmed:issue	9
pubmed:dateCreated	2006-11-13
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101167661
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1543-0790
pubmed:author	pubmed-author:AdèsLionelL, pubmed-author:FenauxPierreP
pubmed:issnType	Print
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	678-82
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:17099625-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17099625-Cytarabine, pubmed-meshheading:17099625-Humans, pubmed-meshheading:17099625-Leukemia, Promyelocytic, Acute, pubmed-meshheading:17099625-Randomized Controlled Trials as Topic, pubmed-meshheading:17099625-Recurrence, pubmed-meshheading:17099625-Risk Factors, pubmed-meshheading:17099625-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
pubmed:affiliation	Service d'Hématologie clinique at the Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Avicenne, 93009 Bobigny, France.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't